Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 902.37% | 1.56% | 521.34% | -- | 171.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 902.37% | 1.56% | 521.34% | -- | 171.96% |
| Cost of Revenue | 725.55% | -23.65% | 624.00% | -- | -- |
| Gross Profit | 969.60% | 18.27% | 477.40% | -- | -- |
| SG&A Expenses | 10.49% | -64.16% | -44.70% | 48.68% | 126.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 213.01% | -56.42% | -4.26% | 49.74% | 121.52% |
| Operating Income | 26,300.00% | 109.77% | 137.09% | -35.11% | -98.46% |
| Income Before Tax | 3,828.62% | 101.08% | 128.25% | -67.32% | -112.77% |
| Income Tax Expenses | -- | -- | 0.00% | -- | 100.00% |
| Earnings from Continuing Operations | 3,828.62% | 101.08% | 127.77% | -67.32% | -112.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,828.62% | 101.08% | 127.77% | -253.70% | 85.75% |
| EBIT | 26,300.00% | 109.77% | 137.09% | -35.11% | -98.46% |
| EBITDA | 25,014.63% | 109.77% | 137.22% | -35.49% | -98.16% |
| EPS Basic | 3,971.43% | 100.95% | 128.07% | -254.29% | 89.23% |
| Normalized Basic EPS | 3,480.00% | 101.02% | 128.57% | -70.00% | -120.00% |
| EPS Diluted | 7,328.57% | 100.95% | 128.07% | -254.29% | 89.23% |
| Normalized Diluted EPS | 3,480.00% | 101.02% | 128.57% | -70.00% | -120.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 11.94% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 11.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |